License, Collaboration and Other Agreements - Additional Information (Detail) - USD ($)	1 Months Ended	2 Months Ended	3 Months Ended		12 Months Ended
	Feb. 28, 2023	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Collaboration Revenue [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Revenue					$ 10,000,000.0
Additional Collaboration Revenue [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Revenue			$ 0	$ 0
Kyorin Pharmaceutical Co Ltd [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Upfront and milestone payments received		$ 20,000,000.0
Milestone payments received	$ 10,000,000.0		$ 10,000,000.0		$ 10,000,000.0
Development Regulatory And Sales Milestones [Member] | Kyorin Pharmaceutical Co Ltd [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Remaining receivable based on achievement of research milestones	$ 155,000,000.0